Jessica Erriquez

IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies

Sabine Tejpar, Eva Budinská, Claudio Isella, 2015, Science Translational Medicine.